DCPH
Price:
$25.59
Market Cap:
$2.21B
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-09-28
Stock Exchange
NASDAQ
Ticker
DCPH
According to Deciphera Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.15B. This represents a change of 78.71% compared to the average of 1.20B of the last 4 quarters.
The mean historical Enterprise Value of Deciphera Pharmaceuticals, Inc. over the last ten years is 1.11B. The current 2.15B Enterprise Value has changed 19.27% with respect to the historical average. Over the past ten years (40 quarters), DCPH's Enterprise Value was at its highest in in the June 2020 quarter at 3.20B. The Enterprise Value was at its lowest in in the September 2017 quarter at -41544327.50.
Average
1.11B
Median
511.28M
Minimum
185.41M
Maximum
3.08B
Discovering the peaks and valleys of Deciphera Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 455.64%
Maximum Annual Enterprise Value = 3.08B
Minimum Annual Increase = -83.39%
Minimum Annual Enterprise Value = 185.41M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.31B | 9.37% |
2022 | 1.20B | 135.06% |
2021 | 511.28M | -83.39% |
2020 | 3.08B | 20.01% |
2019 | 2.57B | 455.64% |
2018 | 461.72M | 149.03% |
2017 | 185.41M | -40.78% |
2016 | 313.07M | -9.24% |
The current Enterprise Value of Deciphera Pharmaceuticals, Inc. (DCPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.01B
5-year avg
1.73B
10-year avg
1.11B
Deciphera Pharmaceuticals, Inc.’s Enterprise Value is greater than Eagle Pharmaceuticals, Inc. (110.03M), greater than ANI Pharmaceuticals, Inc. (1.34B), greater than Phibro Animal Health Corporation (1.24B), less than Prestige Consumer Healthcare Inc. (4.75B), greater than Evotec SE (1.33B), greater than Supernus Pharmaceuticals, Inc. (1.85B), greater than Collegium Pharmaceutical, Inc. (1.58B), less than Neurocrine Biosciences, Inc. (12.29B), greater than Ironwood Pharmaceuticals, Inc. (1.26B), less than Alkermes plc (4.26B), greater than Avadel Pharmaceuticals plc (1.40B), less than Amphastar Pharmaceuticals, Inc. (2.64B), greater than Procaps Group S.A. (491.27M), greater than Silver Spike Investment Corp. (38.06M),
Company | Enterprise Value | Market cap |
---|---|---|
110.03M | $55.19M | |
1.34B | $1.27B | |
1.24B | $788.20M | |
4.75B | $3.68B | |
1.33B | $1.19B | |
1.85B | $1.86B | |
1.58B | $1.20B | |
12.29B | $12.13B | |
1.26B | $720.42M | |
4.26B | $4.42B | |
1.40B | $1.39B | |
2.64B | $2.21B | |
491.27M | $218.91M | |
38.06M | $71.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Deciphera Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Deciphera Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Deciphera Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Deciphera Pharmaceuticals, Inc. (DCPH)?
What is the 3-year average Enterprise Value for Deciphera Pharmaceuticals, Inc. (DCPH)?
What is the 5-year average Enterprise Value for Deciphera Pharmaceuticals, Inc. (DCPH)?
How does the current Enterprise Value for Deciphera Pharmaceuticals, Inc. (DCPH) compare to its historical average?